Background Image

What is a virtual company?

A virtual biotech company maintains minimal infrastructure by using partnerships with expert service providers to advance the development of its assets. With proper leadership and management, out-sourcing drug development to the most appropriate experts can speed up progress, improve outcomes and reduce costs.

SuperX benefits from the expertise of the out-sourced drug development firms it works with, including Total Scientific, RxCelerate, Cambridge ProteinWorks and FairJourney Biologics (http://fjb.pt/).

What is an asset-centric company?

The term asset-centric is used to refer to biotech companies developing a single asset. This ensures the entire focus of the management team and all the available resources are directed towards the successful development of that asset.